Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Follow ZDNET: Add us as a preferred source on Google. Web browsers are among the most essential pieces of software we use daily, yet we often take them for granted. Most users settle for whatever ...

SALINE TWP., MI — Saline Township officials got an earful from residents opposed to a massive $7 billion, 2.2 million-square-foot data center for tech giants like OpenAI and Oracle to use. Some ...

Migrating legacy Oracle databases to the cloud is a critical step for organizations aiming to modernize their infrastructure and enhance operational efficiency. In this blog post, we’ll walk through a ...

To connect your OnePlus (or even Oppo or Vivo) phone to a Mac using O+ Connect, download the O+ Connect app, install it on your Mac, and ensure both devices are on the same Wi-Fi and Bluetooth is ...

The new browser, called Atlas, is designed to work closely with OpenAI products like ChatGPT. By Cade Metz Reporting from San Francisco OpenAI on Tuesday unveiled a free web browser that is designed ...

Hyperscalers leased approximately 7.4 gigawatts of U.S. data center capacity in the third quarter of this year. That is more capacity than was leased in all of 2024, according to a TD Cowen note ...

Oracle has released GraalVM for JDK 25, introducing new features for its native image technology, while confirming that future development of the platform will shift away from the Java release cycle ...

The enterprise software industry is undergoing its most radical transformation in decades. Once dominated by static systems and manual workflows, it’s rapidly evolving into a dynamic, intelligent ...

Companies across many industries are implementing AI agents for internal use, automating a wide range of tasks. In the financial sector, AI agents are critical for fraud detection. They can analyze ...

Feasibility of circulating tumor DNA-based minimal residual disease (ctDNA-MRD)-guided adjuvant chemotherapy in patients with stage II-III gastric cancer (GC): An adaptive trial (MRD-GATE).